Publications by authors named "Michael Giacomantonio"

Article Synopsis
  • - CD8 T cells are crucial for fighting viruses, and type I interferons quickly activate them after viral exposure, leading to changes in their behavior.
  • - The study reveals that exposure to reovirus activates naïve CD8 T cells within 24 hours, highlighting a previously overlooked role of these cells in the immune response.
  • - The activation of naïve CD8 T cells is dependent on a protein called STAT1 and is influenced by a metabolic process involving nicotinamide phosphoribosyl transferase (NAMPT), suggesting new insights into immune responses to viruses.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates how cancer cell energy metabolism, particularly NAD+ levels, influences the effectiveness of oncolytic viruses like reovirus in treating multiple myeloma.
  • - Researchers found that lower NAD+ levels, from inhibiting the enzyme NAMPT, made multiple myeloma cells more susceptible to reovirus-induced killing, especially in cells with active p53 and a preference for mitochondrial metabolism.
  • - The combination treatment of reovirus and NAD+ depletion led to significant mitochondrial dysfunction and cell death in specific myeloma cells, indicating that targeting NAD+ levels could enhance oncolytic virus therapies in multiple myeloma patients.
View Article and Find Full Text PDF

Introduction: Aldehyde dehydrogenase 1A3 (ALDH1A3) is a cancer stem cell (CSC) marker and in breast cancer it is associated with triple-negative/basal-like subtypes and aggressive disease. Studies on the mechanisms of ALDH1A3 in cancer have primarily focused on gene expression changes induced by the enzyme; however, its effects on metabolism have thus far been unstudied and may reveal novel mechanisms of pathogenesis.

Objective: Determine how ALDH1A3 alters the metabolite profile in breast cancer cells and assess potential impacts.

View Article and Find Full Text PDF

Oncolytic reovirus preferentially targets and kills cancer cells via the process of oncolysis, and additionally drives clinically favorable antitumor T cell responses that form protective immunological memory against cancer relapse. This two-prong attack by reovirus on cancers constitutes the foundation of its use as an anticancer oncolytic agent. Unfortunately, the efficacy of these reovirus-driven antitumor effects is influenced by the highly suppressive tumor microenvironment (TME).

View Article and Find Full Text PDF

The efficacy of oncolytic viruses (OVs), such as reovirus, is dictated by host immune responses, including those mediated by the pro- versus anti-inflammatory macrophages. As such, a detailed understanding of the interaction between reovirus and different macrophage types is critical for therapeutic efficacy. To explore reovirus-macrophage interactions, we performed tandem mass tag (TMT)-based quantitative temporal proteomics on mouse bone marrow-derived macrophages (BMMs) generated with two cytokines, macrophage colony stimulating factor (M-CSF) and granulocytic-macrophage colony stimulating factor (GM-CSF), representing anti- and proinflammatory macrophages, respectively.

View Article and Find Full Text PDF
Article Synopsis
  • * The study revealed that cancer cells' response to reovirus infection is linked to changes in their metabolism, particularly involving pyruvate and oxidative stress, which influences their overall susceptibility to the virus.
  • * Therapeutically, enhancing the activity of an enzyme called pyruvate dehydrogenase (PDH) in cancer cells can make them more vulnerable to reovirus treatment, suggesting that modifying cancer cell metabolism could be an effective strategy to improve oncolytic virus therapies.
View Article and Find Full Text PDF

NAD is a key metabolic redox cofactor that is regenerated from nicotinamide through the NAD salvage pathway. Here, we find that inhibiting the NAD salvage pathway depletes serine biosynthesis from glucose by impeding the NAD-dependent protein, 3-phosphoglycerate dehydrogenase (PHGDH). Importantly, we find that PHGDH breast cancer cell lines are exquisitely sensitive to inhibition of the NAD salvage pathway.

View Article and Find Full Text PDF
Article Synopsis
  • Reticulon-4 (RTN4), known as Nogo, is linked to cancer progression, with lower levels correlating to better survival rates in patients with various cancers like lung and breast cancer.
  • Research using mass spectrometry revealed that knocking down RTN4 affects key processes like lipid homeostasis and AKT signaling, which are important for cancer cell survival and growth.
  • RTN4 deficiency not only inhibited cancer cell proliferation in lab tests and animal models but also enhanced the effectiveness of chemotherapy, suggesting it could be a potential target for cancer treatment.
View Article and Find Full Text PDF

Immunogenic cell death (ICD) activates both innate and adaptive arms of the immune system during apoptotic cancer cell death. With respect to cancer immunotherapy, the process of ICD elicits enhanced adjuvanticity and antigenicity from dying cancer cells and consequently, promotes the development of clinically desired antitumor immunity. Cancer ICD requires the presentation of various "hallmarks" of immunomodulation, which include the cell-surface translocation of calreticulin, production of type I interferons, and release of high-mobility group box-1 and ATP, which through their compatible actions induce an immune response against cancer cells.

View Article and Find Full Text PDF

Breast cancer stem cells (CSCs) can be identified by increased Aldefluor fluorescence caused by increased expression of aldehyde dehydrogenase 1A3 (ALDH1A3), as well as ALDH1A1 and ALDH2. In addition to being a CSC marker, ALDH1A3 regulates gene expression via retinoic acid (RA) signaling and plays a key role in the progression and chemotherapy resistance of cancer. Therefore, ALDH1A3 represents a druggable anti-cancer target of interest.

View Article and Find Full Text PDF

Introduction: Incisional biopsies, including the diagnostic core needle biopsy (CNB), routinely performed before surgical excision of breast cancer tumors are hypothesized to increase the risk of metastatic disease. In this study, we experimentally determined whether CNB of breast cancer tumors results in increased distant metastases and examine important resultant changes in the primary tumor and tumor microenvironment associated with this outcome.

Method: To evaluate the effect of CNB on metastasis development, we implanted murine mammary 4T1 tumor cells in BALB/c mice and performed CNB on palpable tumors in half the mice.

View Article and Find Full Text PDF

Introduction: Several studies have examined predictors of publication of research presented in scientific meetings in different disciplines. A tendency toward publishing studies with positive results has been described as "publication bias." Our objective was to determine the proportion of the studies that were published, time to publication, and factors that could predict publication in pediatric surgery.

View Article and Find Full Text PDF

A 4.5-year-old boy presented with isosexual precocious puberty and an anterior mediastinal mass. Surgical resection demonstrated a teratoma with foci of malignant mixed germ cell tumor elements of polyembryoma.

View Article and Find Full Text PDF

Background: There are many reports on the complications that occur at the time of insertion and during the life of central venous indwelling catheters. However, there is no literature that describes the complications that occur at the time of removal of these lines.

Methods: A retrospective review of 136 central line (Broviacs [B], Port-A- Caths [PC] and Hickmans [HC]) removals during the last 5 years was undertaken.

View Article and Find Full Text PDF

Mesenchymal neoplasms of the esophagus are relatively uncommon in adults and exceedingly rare in children. Childhood tumors consist almost exclusively of smooth muscle tumors (leiomyomas). We report a case of an undifferentiated mesenchymal neoplasm occurring in the distal esophagus of a 15-year-old boy which is not a gastrointestinal stromal tumor.

View Article and Find Full Text PDF